EVLO — Evelo Biosciences Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Evelo Biosciences Announces Dosing Of First Patient In Phase 2 Trial Of Edp1815 In Atopic Dermatitis
Brief: Evelo Biosciences Announces Highly Significant Reductions In Clinically Validated Inflammatory Cytokines In EDP1815 Phase 2 Psoriasis Trial
Brief: Evelo Biosciences Presents Data On EDP1815 Mechanism Of Action And Supporting Ongoing Clinical Development For Inflammatory Diseases
Brief: Evelo Biosciences Inc - Co Announced Planned Updates To The Study Protocol For Its Phase 2 Clinical Trial Of EDP1815 In Atopic Dermatitis
Brief: Evelo Biosciences Added To Nasdaq Biotechnology Index
Evelo Biosciences Inc reports results for the quarter ended in September - Earnings Summary
Evelo Biosciences Inc expected to post a loss of 54 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Blade Air Mobility, Travel + Leisure, Vail Resorts
Brief: Evelo Biosciences Announces Issuance Of U.S. Patent For Pharmaceutical Compositions Of Single Strains Of Naturally Occurring Bacteria As Medicines
Brief: Evelo Biosciences Appoints Iain Mcinnes To Board Of Directors
Brief: Evelo Biosciences Inc Files For Mixed Shelf Of Up To $200 Mln
Evelo Biosciences Inc reports results for the quarter ended in June - Earnings Summary
Evelo Biosciences Inc expected to post a loss of 54 cents a share - Earnings Preview
Brief: Evelo Biosciences Announces Appointment Of Mark Plinio As Chief Commercial Officer
Evelo Biosciences Inc reports results for the quarter ended in March - Earnings Summary
Brief: Evelo Biosciences Reports Q1 2021 Financial Results
U.S. STOCKS ON THE MOVE-Skechers, Snap, Mattel, Skillz, Silicon Laboratories
Brief: Evelo Biosciences Presents Further Positive Data From Phase 1B Clinical Trial Of Edp1815 In Atopic Dermatitis
Brief: Evelo Biosciences Announces Appointments Of Luca Scavo As CFO And Julie Mchugh To The Board Of Directors